Vaxart, Inc. Appoints Steven Lo as CEO

San Francisco, CA, March 06, 2024 (GlobeNewswire) -- Vaxart, Inc. (Nasdaq: VXRT) has named Steven Lo as its President and Chief Executive Officer, effective from March 18, 2024, and he will also join the Board of Directors. With an impressive track record spanning over 25 years in the healthcare, biotechnology, and pharmaceutical sectors, including extensive C-level experience, Mr. Lo brings formidable leadership to Vaxart. Dr. Michael J. Finney, previously serving as interim Chief Executive Officer, will transition to the role of Chair of the Board of Directors, expressing confidence in Lo's ability to lead the company through its next phase of growth and innovation.

Read full article here.